Colorectal Cancer Therapeutics: Global Markets

Apr 2019| PHM211A| BCC Publishing

Report Highlights

The global colorectal cancer therapeutics market should reach $18.5 billion by 2023 from $13.7 billion in 2018 at a compound annual growth rate (CAGR) of 6.1% for the period 2018 to 2023.

Report Includes

  • 39 data tables and 18 additional tables
  • Detailed overview of the colorectal cancer (CRC) therapeutics and corresponding global markets
  • Country specific data and analysis for France, Germany, Italy, U.K., Spain, Russia, India, China, Japan, United States, Canada, Middle East and Africa
  • Evaluation of market dynamics with a focus on increasing prevalence of colorectal cancer cases, technological advancements in radiology and chemotherapy, and increasing cancer prevention initiatives
  • Coverage of some of the significant CRC tests including CT colonography, double-contrast barium enema, and biopsy test and their usability study and future growth potential
  • A look into regulatory environment, new products launces and technological advancements, and current strategies within the market
  • Company profiles of major manufacturers and suppliers of CRC therapeutic drugs, including Abbott Laboratories, Bayer Healthcare, GlaxoSmithKline, Merck & Co. Inc., Pfizer, Inc. and Sanofi S.A.

Report Scope

This report is a business analysis that examines market trends for colorectal cancer therapeutics. The report includes sections on the following topics:

  • Current prevalence of colorectal cancer, trend analysis and factors influencing future incidence.
  • Market analysis by treatment type, including annual incidence and trend analysis.
  • Risk factors and other drivers that may impact the future incidence of colorectal cancer.
  • Review of the major market opportunities by identifying specific high-growth and emerging market opportunities.
  • Market share and information on key market players.
  • Analysis and forecast of the revenues for colorectal cancer treatment for the global market, major market subsegments subdivided by geographic region and further, by selected country.
  • Detailed review of the current products, their indications for all identified market segments.
  • Profile of the individual market subsegments within the major market segments analyzed and the distinguishing features of each of the market subsegments.

This report captures colorectal cancer therapeutics market revenue for different regions by treatment type, i.e., chemotherapy, targeted therapy and immunotherapy used for treating the disease. A detailed colorectal cancer therapeutics market analysis covers the regions of North America, Europe, Asia-Pacific, and Rest of World.

Market values are provided using 2017 as base year, 2018 as estimated year, and 2023 as forecasted year. Estimated values used are based on manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Latest reports include:

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at
Title/Chapter NamePagesPrice Member Price
Full Report: Colorectal Cancer Therapeutics: Global Markets124 $2,750 Free
Chapter- 1: Introduction5Free
Chapter- 2: Summary and Highlights2$250Free
Chapter- 3: Overview and Biology18$409Free
Chapter- 4: Colorectal Cancer Market Dynamics5$114Free
Chapter- 5: Pipeline Analysis14$318Free
Chapter- 6: Global Colorectal Cancer Therapeutics Market Breakdown by Treatment Type13$295Free
Chapter- 7: Global Colorectal Cancer Therapeutics Market Breakdown by Region28$636Free
Chapter- 8: Regulatory and Reimbursement Structure8$182Free
Chapter- 9: Competitive Landscape and Key Developments4$91Free
Chapter- 10: Company Profiles24$545Free
Chapter- 11: Appendix3$68Free
Colorectal Cancer Therapeutics: Global Markets

Single User License: $2750

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries